Single‐nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867015179303124992 |
|---|---|
| author | Silvia González‐Martínez José Palacios Irene Carretero‐Barrio Val Fernández‐Lanza Alfonso Cortés‐Salgado Javier Román Xavier Matias‐Guiu Sonia Gatius Javier Cortés Belén Pérez‐Mies |
| author_facet | Silvia González‐Martínez José Palacios Irene Carretero‐Barrio Val Fernández‐Lanza Alfonso Cortés‐Salgado Javier Román Xavier Matias‐Guiu Sonia Gatius Javier Cortés Belén Pérez‐Mies Silvia González‐Martínez José Palacios Irene Carretero‐Barrio Val Fernández‐Lanza Alfonso Cortés‐Salgado Javier Román Xavier Matias‐Guiu Sonia Gatius Javier Cortés Belén Pérez‐Mies |
| collection | Wiley Open Access |
| contents | Single‐nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification Silvia González‐Martínez José Palacios Irene Carretero‐Barrio Val Fernández‐Lanza Alfonso Cortés‐Salgado Javier Román Xavier Matias‐Guiu Sonia Gatius Javier Cortés Belén Pérez‐Mies The Journal of Pathology Abstract Carcinosarcomas (CSs) are aggressive biphasic tumors characterized by epithelial and mesenchymal components, whose histogenesis and differentiation dynamics remain poorly understood. We present single‐nucleus RNA sequencing (snRNA‐seq) analysis of six CSs (five endometrial and one ovarian) and two normal endometrial samples, profiling over 96,298 cells. By integrating transcriptomic data with inferred copy number variations (CNVs), immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and in situ hybridization (ISH) validation, we resolved the complex cellular architecture of these tumors, identified lineage‐specific programs, and revealed unexpected differentiation trajectories. snRNA‐seq was used to further refine the histopathological classification of three cases by uncovering heterologous differentiation not previously recognized: one rhabdomyogenic, one osteogenic, and, notably, one exhibiting a novel tenogenic program, defined by the expression of SCX , MKX , and TNMD . All CSs displayed a prominent mesenchymal compartment comprising both undifferentiated fibroblast‐like cells and distinct lineage committed populations, including rhabdomyoblasts (Rhab), tenoblasts (Teno), osteoblasts (Osteo), and chondroblasts (Chond). In some tumors, multiple mesenchymal identities co‐existed, and in others, differentiation gradients (e.g. immature versus mature rhabdomyoblasts) were observed. These patterns underscore the cellular plasticity and multilineage potential of the sarcomatous component. Furthermore, the expression of specialized interface markers ( COL22A1 , NCAM1 , ACAN , CHRNG , MUSK ) suggests that some tumors use structured developmental programs reminiscent of the muscle–tendon junction, enthesis, or neuromuscular junction. CNV analysis revealed tumor‐specific genomic alterations with clonal and subclonal patterns linked to differentiation state, which were validated by FISH. Altogether, this study demonstrates that CSs are not static biphasic tumors but rather complex ecosystems with extensive developmental plasticity. Our findings redefine their classification and support the use of single‐nucleus approaches to uncover hidden differentiation trajectories in highly heterogeneous cancers, including the discovery of a previously unreported tenogenic lineage. Our results challenge the diagnosis of homologous CS when only morphological criteria are applied. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.70003 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1002/path.70003 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_path_70003 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2026 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Single‐nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification Silvia González‐Martínez José Palacios Irene Carretero‐Barrio Val Fernández‐Lanza Alfonso Cortés‐Salgado Javier Román Xavier Matias‐Guiu Sonia Gatius Javier Cortés Belén Pérez‐Mies The Journal of Pathology Single‐nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification Silvia González‐Martínez José Palacios Irene Carretero‐Barrio Val Fernández‐Lanza Alfonso Cortés‐Salgado Javier Román Xavier Matias‐Guiu Sonia Gatius Javier Cortés Belén Pérez‐Mies The Journal of Pathology Abstract Carcinosarcomas (CSs) are aggressive biphasic tumors characterized by epithelial and mesenchymal components, whose histogenesis and differentiation dynamics remain poorly understood. We present single‐nucleus RNA sequencing (snRNA‐seq) analysis of six CSs (five endometrial and one ovarian) and two normal endometrial samples, profiling over 96,298 cells. By integrating transcriptomic data with inferred copy number variations (CNVs), immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and in situ hybridization (ISH) validation, we resolved the complex cellular architecture of these tumors, identified lineage‐specific programs, and revealed unexpected differentiation trajectories. snRNA‐seq was used to further refine the histopathological classification of three cases by uncovering heterologous differentiation not previously recognized: one rhabdomyogenic, one osteogenic, and, notably, one exhibiting a novel tenogenic program, defined by the expression of SCX , MKX , and TNMD . All CSs displayed a prominent mesenchymal compartment comprising both undifferentiated fibroblast‐like cells and distinct lineage committed populations, including rhabdomyoblasts (Rhab), tenoblasts (Teno), osteoblasts (Osteo), and chondroblasts (Chond). In some tumors, multiple mesenchymal identities co‐existed, and in others, differentiation gradients (e.g. immature versus mature rhabdomyoblasts) were observed. These patterns underscore the cellular plasticity and multilineage potential of the sarcomatous component. Furthermore, the expression of specialized interface markers ( COL22A1 , NCAM1 , ACAN , CHRNG , MUSK ) suggests that some tumors use structured developmental programs reminiscent of the muscle–tendon junction, enthesis, or neuromuscular junction. CNV analysis revealed tumor‐specific genomic alterations with clonal and subclonal patterns linked to differentiation state, which were validated by FISH. Altogether, this study demonstrates that CSs are not static biphasic tumors but rather complex ecosystems with extensive developmental plasticity. Our findings redefine their classification and support the use of single‐nucleus approaches to uncover hidden differentiation trajectories in highly heterogeneous cancers, including the discovery of a previously unreported tenogenic lineage. Our results challenge the diagnosis of homologous CS when only morphological criteria are applied. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.70003 http://creativecommons.org/licenses/by/4.0/ |
| title | Single‐nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification |
| topic | The Journal of Pathology |
| url | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.70003 |